School Of Medicine Basic Sciences
-
Targeting immune suppression to overcome melanoma resistance
Ann Richmond outlines a promising therapeutic strategy that may re-sensitize treatment-resistant tumors to immunotherapy. The research introduces a three-drug combination that enhances immune activity and suppresses tumor-promoting immune cells. Read MoreFeb. 16, 2026
-
Nakagawa to deliver inaugural Kairos Lecture on Feb. 26
Dr. Teru Nakagawa, professor of molecular physiology and biophysics in the School of Medicine Basic Sciences, will deliver the inaugural Kairos Lecture on Thursday, Feb. 26, 2026. Read MoreFeb. 15, 2026
-
Celebrating love found
Whether they met at the bench or bonded over research setbacks, these alums prove that meaningful relationships can flourish alongside rigorous scientific training. In honor of Valentine’s Day, we asked them to share how they did it. Read MoreFeb. 12, 2026
-
Introducing the School of Medicine Basic Sciences Kairos Lecture Series
The School of Medicine Basic Sciences is launching a new lecture series: “The Kairos Lectures: Research of Consequence at the Right Moment.” Read MoreFeb. 12, 2026
-
ASPIRE Down the Road: Exploring the local pharmaceutical industry in Nashville
Vanderbilt trainees and postdocs explored Nashville’s biotech scene, starting with contract research organization Inotiv. Read MoreFeb. 10, 2026
-
Prolonged semaglutide treatment reveals distinct stages of weight loss, maintenance, and regain
In a new study published in Diabetes, researchers found that prolonged treatment with the GLP-1R agonist semaglutide led to changes in feeding habits and fuel use in an animal model, offering new insights into the behavioral and metabolic adaptations that accompany weight loss, weight maintenance, and rapid weight regain after stopping treatment. Read MoreFeb. 10, 2026
-
School of Medicine Basic Sciences Staff Spotlight: Prashant Singh
Meet Prashant Singh, senior research associate in the Tina Iverson lab within the School of Medicine Basic Sciences. Read MoreFeb. 6, 2026
-
Aging researchers find new puzzle piece in the game of longevity
The lab of Kris Burkewitz just made a key discovery: How cellular machineries are structured and organized within a cell has implications for healthy aging. “We didn't just add a piece to the puzzle—we found a whole section that hasn't even been touched,” Eric Donahue, first author of the study, said. Read MoreFeb. 2, 2026
-
Kidney Disease Research
Kidney Disease Vanderbilt School of Medicine’s Basic Sciences investigators study kidney cancer and kidney disease from molecules to patients. Teams link genomics, epigenetics, and metabolism to clear cell renal cell carcinoma initiation, therapy resistance, and tumor-immune microenvironment. Researchers build organoid, CRISPR, and mouse models to test pathways and identify drug… Read MoreJan. 29, 2026
-
Gallbladder Disease Research
Gallbladder Disease Research Vanderbilt School of Medicine’s Basic Sciences researchers study gallbladder disease by probing the fundamental biology behind gallstone formation and biliary inflammation. Work commonly integrates cell and animal models with human biospecimens. Investigators explore genetic and environmental risk factors, including diet and the gut-liver-biliary axis, and apply modern… Read MoreJan. 29, 2026